These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34522200)

  • 41. Searching for Potential Novel BCR-ABL Tyrosine Kinase Inhibitors Through G-QSAR and Docking Studies of Some Novel 2-Phenazinamine Derivatives.
    Kale M; Sonwane G; Choudhari Y
    Curr Comput Aided Drug Des; 2020; 16(5):501-510. PubMed ID: 30345925
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 3D QSAR, Docking, Molecular Dynamics Simulations and MM-GBSA studies of Extended Side Chain of the Antitubercular Drug (6S) 2-Nitro-6- {[4-(trifluoromethoxy) benzyl] oxy}-6,7-dihydro-5H-imidazo[2,1-b] [1,3] oxazine.
    Chaudhari HK; Pahelkar A
    Infect Disord Drug Targets; 2019; 19(2):145-166. PubMed ID: 30324898
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 2D- and 3D-QSAR modelling, molecular docking and
    Shukla A; Tyagi R; Meena S; Datta D; Srivastava SK; Khan F
    J Biomol Struct Dyn; 2020 Jan; 38(1):168-185. PubMed ID: 30686140
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design, synthesis, anti-tumor activity, and molecular modeling of quinazoline and pyrido[2,3-d]pyrimidine derivatives targeting epidermal growth factor receptor.
    Hou J; Wan S; Wang G; Zhang T; Li Z; Tian Y; Yu Y; Wu X; Zhang J
    Eur J Med Chem; 2016 Aug; 118():276-89. PubMed ID: 27132165
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Design, One Pot Synthesis and Molecular Docking Studies of Substituted-1H-Pyrido[2,1-b] Quinazolines as Apoptosis-Inducing Anticancer Agents.
    Bathula R; Satla SR; Kyatham R; Gangarapu K
    Asian Pac J Cancer Prev; 2020 Feb; 21(2):411-421. PubMed ID: 32102519
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 2D-QSAR Modeling and Molecular Docking Studies on 1
    Hajalsiddig TTH; Osman ABM; Saeed AEM
    ACS Omega; 2020 Aug; 5(30):18662-18674. PubMed ID: 32775868
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prediction of new Hsp90 inhibitors based on 3,4-isoxazolediamide scaffold using QSAR study, molecular docking and molecular dynamic simulation.
    Abbasi M; Sadeghi-Aliabadi H; Amanlou M
    Daru; 2017 Jun; 25(1):17. PubMed ID: 28666484
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Design, synthesis, anticancer, antimicrobial activities and molecular docking studies of theophylline containing acetylenes and theophylline containing 1,2,3-triazoles with variant nucleoside derivatives.
    Ruddarraju RR; Murugulla AC; Kotla R; Chandra Babu Tirumalasetty M; Wudayagiri R; Donthabakthuni S; Maroju R; Baburao K; Parasa LS
    Eur J Med Chem; 2016 Nov; 123():379-396. PubMed ID: 27487568
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dataset on the DFT-QSAR, and docking approaches for anticancer activities of 1, 2, 3-triazole-pyrimidine derivatives against human esophageal carcinoma (EC-109).
    Adegoke RO; Oyebamiji AK; Semire B
    Data Brief; 2020 Aug; 31():105963. PubMed ID: 32695851
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparative QSAR analysis and molecular docking studies of phenyl piperidine derivatives as potent dual NK
    Zare S; Fereidoonnezhad M; Afshar D; Ramezani Z
    Comput Biol Chem; 2017 Apr; 67():22-37. PubMed ID: 28043073
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ANN-QSAR model for virtual screening of androstenedione C-skeleton containing phytomolecules and analogues for cytotoxic activity against human breast cancer cell line MCF-7.
    Prakash O; Khan F; Sangwan RS; Misra L
    Comb Chem High Throughput Screen; 2013 Jan; 16(1):57-72. PubMed ID: 23030276
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structure based virtual screening, 3D-QSAR, molecular dynamics and ADMET studies for selection of natural inhibitors against structural and non-structural targets of Chikungunya.
    Vora J; Patel S; Sinha S; Sharma S; Srivastava A; Chhabria M; Shrivastava N
    J Biomol Struct Dyn; 2019 Aug; 37(12):3150-3161. PubMed ID: 30114965
    [TBL] [Abstract][Full Text] [Related]  

  • 53. QSAR and docking based semi-synthesis and in vitro evaluation of 18 β-glycyrrhetinic acid derivatives against human lung cancer cell line A-549.
    Yadav DK; Kalani K; Khan F; Srivastava SK
    Med Chem; 2013 Dec; 9(8):1073-84. PubMed ID: 23675978
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dexibuprofen amide derivatives as potential anticancer agents: synthesis, in silico docking, bioevaluation, and molecular dynamic simulation.
    Ashraf Z; Mahmood T; Hassan M; Afzal S; Rafique H; Afzal K; Latip J
    Drug Des Devel Ther; 2019; 13():1643-1657. PubMed ID: 31190743
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anti-tubercular Modelling via QSAR Approach, In Silico Design and Virtual Docking Screening of Designed Hypothetical Inhibitors Against DNA gyrase Protein.
    Adeniji SE
    Curr Comput Aided Drug Des; 2021; 17(6):739-758. PubMed ID: 32586260
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In-silico Studies and Wet-Lab Validation of Camptothecin Derivatives for Anti-Cancer Activity Against Liver (HepG2) and Lung (A549) Cancer Cell Lines.
    Kalani K; Yadav DK; Alam S; Khan F; Kashyap MP; Srivastava SK; Pant AB
    Curr Top Med Chem; 2021; 21(10):908-919. PubMed ID: 33902420
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Potential Inhibitors of Galactofuranosyltransferase 2 (GlfT2): Molecular Docking, 3D-QSAR, and In Silico ADMETox Studies.
    Ortiz CLD; Completo GC; Nacario RC; Nellas RB
    Sci Rep; 2019 Nov; 9(1):17096. PubMed ID: 31745103
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In silico development, validation and comparison of predictive QSAR models for lipid peroxidation inhibitory activity of cinnamic acid and caffeic acid derivatives using multiple chemometric and cheminformatics tools.
    Mitra I; Saha A; Roy K
    J Mol Model; 2012 Aug; 18(8):3951-67. PubMed ID: 22434311
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantitative structure-activity relationship and molecular docking of artemisinin derivatives to vascular endothelial growth factor receptor 1.
    Saeed ME; Kadioglu O; Seo EJ; Greten HJ; Brenk R; Efferth T
    Anticancer Res; 2015 Apr; 35(4):1929-34. PubMed ID: 25862844
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis, cytotoxic evaluation, and molecular docking studies of novel quinazoline derivatives with benzenesulfonamide and anilide tails: Dual inhibitors of EGFR/HER2.
    Alkahtani HM; Abdalla AN; Obaidullah AJ; Alanazi MM; Almehizia AA; Alanazi MG; Ahmed AY; Alwassil OI; Darwish HW; Abdel-Aziz AA; El-Azab AS
    Bioorg Chem; 2020 Jan; 95():103461. PubMed ID: 31838290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.